Sun, Wockhardt recall drugs from US market

Hyderabad: Sun Pharma and Wockhardt have separately initiated voluntary recall of a number of drugs from the US market due to different reasons.

Representational image. AFP

Sun Pharma initiated voluntary recall of multiple lots of Bupropion Hydrochloride Extended-¬release Tablets USP (SR), 200 mg, 60-count bottle, from the US market for “failed dissolution specification”, while Wockhardt started recalling its Lisinopril Tablets USP, 5 mg and 20 mg from the same market for “CGMP violations”.

According to a notification issued by the US Food and Drug Administration, Sun Pharma’s recall was initiated last month under Class-III classification which was as ‘a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences’

Sun, Wockhardt recall drugs from US market

read at……http://www.firstpost.com/business/sun-wockhardt-recall-drugs-from-us-market-2413690.html

India’s Wockhardt to recall some drugs made in India after U.S. FDA concerns

Indian generic drugmaker Wockhardt Ltd said on Tuesday it would recall some drugs manufactured at its two plants in India before the U.S. Food and Drug Administration (FDA) banned those sites due to quality concerns.

The FDA banned U.S. exports from Wockhardt’s Waluj and Chikalthana plants in central India in 2013, citing manufacturing quality lapses.

see

http://www.pharmalive.com/indias-wockhardt-to-recall-some-drugs-made-in-india-after-u-s-fda-concerns/